Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 14, 2021 09:00 ET | Source: CohBar, Inc.

CohBar to Present at the Mitochondria-Targeted Drug Development Summit

MENLO PARK, Calif., April 14, 2021 (GLOBE NEWSWIRE) -- CohBar, Inc. (NASDAQ: CWBR), a clinical stage biotechnology company developing mitochondria based therapeutics to treat chronic diseases and...
March 30, 2021 16:02 ET | Source: CohBar, Inc.

CohBar Reports Fourth Quarter 2020 Financial Results and Provides Business Update

MENLO PARK, Calif., March 30, 2021 (GLOBE NEWSWIRE) -- CohBar, Inc. (NASDAQ: CWBR), a clinical stage biotechnology company developing mitochondria based therapeutics to treat chronic diseases and...
March 29, 2021 09:00 ET | Source: CohBar, Inc.

CohBar Completes Enrollment in the Phase 1b Clinical Trial for CB4211 Under Development for NASH and Obesity

MENLO PARK, Calif., March 29, 2021 (GLOBE NEWSWIRE) -- CohBar, Inc. (NASDAQ: CWBR), a clinical stage biotechnology company developing mitochondria based therapeutics to treat chronic diseases and...
March 16, 2021 16:05 ET | Source: CohBar, Inc.

CohBar to Announce 2020 Fourth Quarter Financial Results and Provide Business Update on March 30, 2021

MENLO PARK, Calif., March 16, 2021 (GLOBE NEWSWIRE) -- CohBar, Inc. (NASDAQ: CWBR), a clinical stage biotechnology company developing mitochondria based therapeutics to treat chronic diseases and...
March 16, 2021 09:00 ET | Source: CohBar, Inc.

CohBar Nominates CB5138 Analog as Lead Clinical Candidate for Idiopathic Pulmonary Fibrosis and other Fibrotic Diseases

MENLO PARK, Calif., March 16, 2021 (GLOBE NEWSWIRE) -- CohBar, Inc. (NASDAQ: CWBR), a clinical stage biotechnology company developing mitochondria based therapeutics to treat chronic diseases and...
March 12, 2021 09:00 ET | Source: CohBar, Inc.

CohBar to Participate in M Vest LLC and Maxim Group LLC Inaugural Emerging Growth Virtual Conference

MENLO PARK, Calif., March 12, 2021 (GLOBE NEWSWIRE) -- CohBar, Inc. (NASDAQ: CWBR), a clinical stage biotechnology company developing mitochondria based therapeutics to treat chronic diseases and...
March 02, 2021 09:00 ET | Source: CohBar, Inc.

CohBar to Present at the 33rd Annual ROTH Conference

MENLO PARK, Calif., March 02, 2021 (GLOBE NEWSWIRE) -- CohBar, Inc. (NASDAQ: CWBR), a clinical stage biotechnology company developing mitochondria based therapeutics to treat chronic diseases and...
February 25, 2021 09:00 ET | Source: CohBar, Inc.

CohBar to Present at the H.C. Wainwright Global Life Sciences Conference

MENLO PARK, Calif., Feb. 25, 2021 (GLOBE NEWSWIRE) -- CohBar, Inc. (NASDAQ: CWBR), a clinical stage biotechnology company developing mitochondria based therapeutics to treat chronic diseases and...
February 09, 2021 09:00 ET | Source: CohBar, Inc.

CohBar to Present at the BIO CEO & Investor Digital Conference

MENLO PARK, Calif., Feb. 09, 2021 (GLOBE NEWSWIRE) -- CohBar, Inc. (NASDAQ: CWBR), a clinical stage biotechnology company developing mitochondria based therapeutics to treat chronic diseases and...
January 20, 2021 09:00 ET | Source: CohBar, Inc.

CohBar to Present at the 3rd Annual Longevity Therapeutics Conference

MENLO PARK, Calif., Jan. 20, 2021 (GLOBE NEWSWIRE) -- CohBar, Inc. (NASDAQ: CWBR), a clinical stage biotechnology company developing mitochondria based therapeutics to treat chronic diseases and...